Insider sale
CHINOOK THERAPEUTICS U.S., INC.
$15.24M
695.81K shares
What this filing means
VERSANT VENTURE MANAGEMENT, LLC plans to sell 695.81K shares of CHINOOK THERAPEUTICS U.S., INC. valued at approximately $15.24M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/20/2023ACC: 0001178937-23-000009
695.81K
Shares to sell
$15.24M
Approx. market value
295.81K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Private Placement
Cash
8/22/2019
295.81KTotal acquired295.81K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/22/2019 | Private Placement Cash | 295.81K | — |
| Total | 295.81K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
123.25K
Market value
$2.80M
3/1/2023
—Completed
Units to sell
240K
Market value
$5.46M
3/1/2023
—Completed
Units to sell
36.75K
Market value
$836.1K
3/1/2023
Planned — Approximate Date
NasdaqPlanned
Units to sell
295.81K
Market value
$6.14M
4/17/2023
Total
Units
695.81K
Value
$15.24M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/1/2023 | 123.25K | $2.80M | — | Completed |
3/1/2023 | 240K | $5.46M | — | Completed |
3/1/2023 | 36.75K | $836.1K | — | Completed |
| Planned — Approximate Date | ||||
4/17/2023 | 295.81K | $6.14M | Nasdaq | Planned |
| Total | 695.81K | $15.24M | ||